Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP

Zeiler, Evelyn; Korotkov, Vadim S.; Lorenz-Baath, Katrin; Böttcher, Thomas; Sieber, Stephan A.

Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP

Dateien

Zu diesem Dokument gibt es keine Dateien.

Datum

2012

Autor:innen

Zeiler, Evelyn

Korotkov, Vadim S.

Lorenz-Baath, Katrin

Böttcher, Thomas

Sieber, Stephan A.

Publikationstyp

Zeitschriftenartikel

Publikationsstatus

Published

Erschienen in

Bioorganic & Medicinal Chemistry. 2012, 20(2), pp. 583-591. ISSN 0968-0896. eISSN 1464-3391. Available under: doi: 10.1016/j.bmc.2011.07.047

Zusammenfassung

Here, we report the synthesis and in depth characterization of a second generation β-lactone derived virulence inhibitors. Based on initial results that emphasized the intriguing possibility to disarm bacteria in their virulence the present study develops this concept further and analyses the potential of this strategy for drug development. We were able to expand the collection of bioactive compounds via an efficient synthetic route. Testing of all compounds revealed several hits with anti-virulence activity. Moreover, we demonstrated that these molecules act solely by reducing virulence but not killing bacteria which is an important prerequisite for preserving the useful microbiome. Finally, incubation of lactones with eukaryotic cell lines indicated a tolerable cytotoxicity which is essential for entering animal studies.

Fachgebiet (DDC)

540 Chemie

Zitieren

ISO 690

ZEILER, Evelyn, Vadim S. KOROTKOV, Katrin LORENZ-BAATH, Thomas BÖTTCHER, Stephan A. SIEBER, 2012. Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP. In: Bioorganic & Medicinal Chemistry. 2012, 20(2), pp. 583-591. ISSN 0968-0896. eISSN 1464-3391. Available under: doi: 10.1016/j.bmc.2011.07.047

BibTex

@article{Zeiler2012-01-15Devel-28436,
  year={2012},
  doi={10.1016/j.bmc.2011.07.047},
  title={Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP},
  number={2},
  volume={20},
  issn={0968-0896},
  journal={Bioorganic & Medicinal Chemistry},
  pages={583--591},
  author={Zeiler, Evelyn and Korotkov, Vadim S. and Lorenz-Baath, Katrin and Böttcher, Thomas and Sieber, Stephan A.}
}

RDF

<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28436">
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/28436"/>
    <dc:contributor>Zeiler, Evelyn</dc:contributor>
    <dc:contributor>Korotkov, Vadim S.</dc:contributor>
    <dc:creator>Lorenz-Baath, Katrin</dc:creator>
    <dc:creator>Sieber, Stephan A.</dc:creator>
    <dcterms:title>Development and characterization of improved beta-lactone-based anti-virulence drugs targeting ClpP</dcterms:title>
    <dc:contributor>Sieber, Stephan A.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Böttcher, Thomas</dc:creator>
    <dc:contributor>Böttcher, Thomas</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dcterms:issued>2012-01-15</dcterms:issued>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:creator>Korotkov, Vadim S.</dc:creator>
    <dcterms:bibliographicCitation>Bioorganic &amp; Medicinal Chemistry ; 20 (2012), 2. - S. 583-591</dcterms:bibliographicCitation>
    <dc:rights>terms-of-use</dc:rights>
    <dc:creator>Zeiler, Evelyn</dc:creator>
    <dc:language>eng</dc:language>
    <dc:contributor>Lorenz-Baath, Katrin</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-07-18T08:32:15Z</dcterms:available>
    <dcterms:abstract xml:lang="eng">Here, we report the synthesis and in depth characterization of a second generation β-lactone derived virulence inhibitors. Based on initial results that emphasized the intriguing possibility to disarm bacteria in their virulence the present study develops this concept further and analyses the potential of this strategy for drug development. We were able to expand the collection of bioactive compounds via an efficient synthetic route. Testing of all compounds revealed several hits with anti-virulence activity. Moreover, we demonstrated that these molecules act solely by reducing virulence but not killing bacteria which is an important prerequisite for preserving the useful microbiome. Finally, incubation of lactones with eukaryotic cell lines indicated a tolerable cytotoxicity which is essential for entering animal studies.</dcterms:abstract>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2014-07-18T08:32:15Z</dc:date>
  </rdf:Description>
</rdf:RDF>

Universitätsbibliographie

Nein